Black Rock Inc. Bluebird Bio, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 15,442,212 shares of BLUE stock, worth $61.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,442,212

Previous 15,178,562 1.74%

Holding current value

$61.8 Million

Previous $19.4 Million 22.11%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.85 - $1.26 $224,102 - $332,199	263,650 Added 1.74%	15,442,212 $15.1 Million
Q1 2024 May 10, 2024	BUY	$0.91 - $1.75 $5.64 Million - $10.8 Million	6,195,561 Added 68.97%	15,178,562 $19.4 Million
Q4 2023 Feb 13, 2024	BUY	$1.32 - $4.83 $204,056 - $746,660	154,588 Added 1.75%	8,983,001 $12.4 Million
Q3 2023 Nov 13, 2023	BUY	$3.02 - $4.05 $107,786 - $144,548	35,691 Added 0.41%	8,828,413 $26.8 Million
Q2 2023 Aug 11, 2023	SELL	$2.79 - $5.03 $427,581 - $770,872	-153,255 Reduced 1.71%	8,792,722 $28.9 Million
Q1 2023 May 12, 2023	BUY	$3.14 - $8.22 $4.95 Million - $13 Million	1,577,315 Added 21.41%	8,945,977 $28.4 Million
Q4 2022 Feb 13, 2023	BUY	$5.77 - $8.49 $2.71 Million - $3.99 Million	469,687 Added 6.81%	7,368,662 $51 Million
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $4.07 Million - $8.02 Million	1,085,635 Added 18.67%	6,898,975 $43.7 Million
Q2 2022 Aug 12, 2022	SELL	$2.94 - $5.23 $69,886 - $124,322	-23,771 Reduced 0.41%	5,813,340 $24.1 Million
Q1 2022 May 12, 2022	SELL	$4.07 - $10.6 $304,806 - $793,844	-74,891 Reduced 1.27%	5,837,111 $28.3 Million
Q4 2021 Feb 10, 2022	BUY	$8.96 - $16.31 $1.27 Million - $2.32 Million	142,293 Added 2.47%	5,912,002 $59.1 Million
Q3 2021 Nov 09, 2021	SELL	$11.24 - $21.0 $1.57 Million - $2.93 Million	-139,388 Reduced 2.36%	5,769,709 $110 Million
Q2 2021 Aug 11, 2021	BUY	$18.04 - $22.09 $107 Million - $131 Million	5,909,097 New	5,909,097 $189 Million

Others Institutions Holding BLUE

# of Institutions

Shares Held

20.2M

Call Options Held

Put Options Held

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $308M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account